Lactose (India) Ltd | 142 Cr. | 101 | 247/97.6 | 20.6 | 36.5 | 0.00 % | 18.0 % | 15.5 % | 10.0 |
MPS Pharmaa Ltd | 6.38 Cr. | 3.34 | 4.33/3.05 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 50.1 Cr. | 67.5 | 94.9/44.5 | 17.0 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 40.7 Cr. | 27.8 | 29.0/8.74 | 41.5 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 71.5 Cr. | 94.9 | 155/79.0 | 11.6 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 323 Cr. | 14.2 | 29.0/11.4 | 17.4 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 4.47 Cr. | 9.25 | 27.1/9.25 | 89.4 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 330 Cr. | 699 | 1,024/635 | 17.6 | 277 | 0.10 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 105 Cr. | 24.0 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 813 Cr. | 276 | 449/145 | 23.1 | 98.6 | 0.45 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 6.22 Cr. | 29.6 | 37.6/23.6 | 124 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 6.23 Cr. | 2.50 | 12.7/2.11 | | 17.2 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
Everest Organics Ltd | 244 Cr. | 251 | 307/112 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,088 Cr. | 1,170 | 1,584/970 | 56.5 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 135 Cr. | 1.45 | 2.72/1.03 | 28.6 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 32.7 Cr. | 13.6 | 16.6/6.40 | 39.4 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 12.3 Cr. | 12.2 | 24.6/11.0 | 53.5 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 265 Cr. | 742 | 999/355 | 9.75 | 570 | 0.27 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 33.6 Cr. | 33.6 | 45.0/26.1 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 35.0 Cr. | 76.6 | 84.4/36.0 | 71.5 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 9.50 Cr. | 3.80 | 26.5/2.97 | 38.0 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 16.9 Cr. | 113 | 154/55.1 | 42.3 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 8.54 Cr. | 15.6 | 19.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 49.0 Cr. | 65.0 | 124/55.4 | 31.0 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 4.86 Cr. | 16.2 | 27.8/15.5 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 15,732 Cr. | 907 | 969/347 | 67.0 | 53.3 | 0.11 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 94.6 Cr. | 21.9 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 12.1 Cr. | 23.9 | 46.0/21.2 | 152 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 156 Cr. | 271 | 418/245 | 16.0 | 110 | 1.66 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 23.9 Cr. | 40.6 | 62.6/14.1 | 68.3 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 70,333 Cr. | 1,200 | 1,593/995 | 19.8 | 527 | 0.37 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 146 Cr. | 234 | 307/155 | 41.9 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 792 Cr. | 158 | 265/148 | 15.8 | 60.5 | 1.58 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 33.3 Cr. | 25.5 | 63.2/25.2 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 9,921 Cr. | 2,424 | 2,644/1,008 | 81.6 | 294 | 0.12 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 5.95 Cr. | 0.90 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 287 Cr. | 37.4 | 77.7/34.1 | 20.2 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 7.76 Cr. | 13.3 | 27.3/11.9 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 73.0 Cr. | 3.10 | 6.25/2.82 | 111 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 64,371 Cr. | 30,292 | 31,900/25,200 | 48.2 | 1,657 | 1.35 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 6,898 Cr. | 761 | 837/430 | 27.7 | 205 | 0.39 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 108 Cr. | 38.2 | 75.8/31.3 | 19.0 | 47.8 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,235 Cr. | 811 | 1,078/440 | | 57.7 | 0.12 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 24,678 Cr. | 1,519 | 1,680/489 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 790 Cr. | 241 | 325/131 | 42.5 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 400 Cr. | 299 | 428/270 | 14.4 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,997 Cr. | 710 | 950/433 | 59.0 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,687 Cr. | 1,194 | 1,923/1,060 | 24.6 | 735 | 0.84 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,09,079 Cr. | 3,223 | 3,591/2,505 | 58.6 | 222 | 0.87 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,457 Cr. | 158 | 317/142 | 31.6 | 44.8 | 0.32 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,593 Cr. | 17.0 | 27.9/11.0 | 41.8 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 30,834 Cr. | 1,211 | 1,360/597 | 111 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,727 Cr. | 125 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,28,161 Cr. | 1,784 | 1,960/1,377 | 36.3 | 288 | 0.76 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,240 Cr. | 531 | 886/338 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,846 Cr. | 218 | 398/175 | 29.0 | 70.6 | 0.18 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 327 Cr. | 1,081 | 1,750/612 | 15.5 | 621 | 0.14 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,674 Cr. | 682 | 960/418 | 78.8 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,622 Cr. | 145 | 241/91.8 | 241 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 13,530 Cr. | 5,875 | 7,600/4,146 | 37.3 | 374 | 1.99 % | 49.2 % | 38.6 % | 10.0 |
RPG Life Sciences Ltd | 3,860 Cr. | 2,334 | 2,977/1,381 | 40.4 | 229 | 0.69 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 9,135 Cr. | 5,503 | 5,850/4,637 | 37.2 | 368 | 1.45 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 245 Cr. | 69.4 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 18,835 Cr. | 4,117 | 6,453/3,865 | 30.6 | 820 | 0.85 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 120 Cr. | 97.8 | 348/89.7 | 7.80 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 2,742 Cr. | 448 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 4,185 Cr. | 825 | 1,998/789 | 37.9 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 15,130 Cr. | 11,793 | 18,100/5,540 | 63.0 | 1,087 | 0.12 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 555 Cr. | 24.7 | 56.5/21.9 | 32.6 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 14,854 Cr. | 829 | 1,639/757 | 7.97 | 399 | 1.15 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 2,753 Cr. | 50.2 | 101/41.6 | 21.8 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 9,826 Cr. | 217 | 359/130 | 26.7 | 50.3 | 0.28 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 126 Cr. | 79.8 | 145/74.4 | 12.2 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 385 Cr. | 108 | 177/90.2 | 94.0 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 96,545 Cr. | 2,115 | 2,403/1,493 | 33.7 | 343 | 0.38 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,117 Cr. | 558 | 980/498 | 12.5 | 319 | 0.32 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 32,959 Cr. | 611 | 646/385 | 132 | 79.2 | 0.13 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 709 Cr. | 683 | 1,070/405 | 20.1 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 164 Cr. | 76.0 | 129/60.0 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 940 Cr. | 195 | 370/156 | 19.8 | 103 | 1.54 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 573 Cr. | 356 | 405/294 | 32.0 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 14,382 Cr. | 903 | 1,310/560 | 43.2 | 373 | 0.55 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,691 Cr. | 1,650 | 2,030/1,434 | 40.1 | 207 | 0.74 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,478 Cr. | 223 | 328/109 | 40.6 | 29.7 | 0.90 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 35,697 Cr. | 1,407 | 1,758/1,052 | 48.6 | 264 | 0.28 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,909 Cr. | 65.0 | 108/58.6 | 19.6 | 56.5 | 1.54 % | 12.3 % | 8.68 % | 2.00 |
Ind-Swift Ltd | 79.4 Cr. | 14.7 | 34.7/13.0 | 1.23 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 550 Cr. | 93.1 | 186/81.5 | 6.65 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,169 Cr. | 235 | 388/190 | | 118 | 0.64 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 5,061 Cr. | 410 | 465/262 | 67.9 | 97.6 | 0.29 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,182 Cr. | 1,389 | 3,379/1,253 | 38.2 | 355 | 0.43 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 3,410 Cr. | 340 | 504/278 | 41.6 | 57.3 | 0.03 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 12,305 Cr. | 507 | 725/382 | 25.7 | 141 | 0.30 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 42,744 Cr. | 1,515 | 1,831/936 | | 299 | 0.17 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 49,732 Cr. | 2,936 | 3,088/1,825 | 58.2 | 98.7 | 1.09 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 26,120 Cr. | 1,585 | 2,221/1,411 | 23.3 | 557 | 1.26 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 6,740 Cr. | 414 | 659/364 | 24.6 | 141 | 1.21 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 18,939 Cr. | 1,391 | 1,594/816 | 57.5 | 204 | 0.53 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,00,147 Cr. | 1,200 | 1,421/1,092 | 18.7 | 369 | 0.67 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,556 Cr. | 227 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,23,068 Cr. | 1,524 | 1,702/1,317 | 24.7 | 351 | 0.85 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,189 Cr. | 1,998 | 2,641/1,221 | 29.5 | 334 | 0.25 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 315 Cr. | 120 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,294 Cr. | 123 | 186/92.2 | 15.3 | 95.8 | 0.41 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 72.9 Cr. | 44.8 | 92.0/40.4 | 122 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 41,313 Cr. | 344 | 405/251 | 50.2 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,851 Cr. | 1,925 | 2,326/1,100 | 45.1 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 142 Cr. | 89.2 | 158/76.3 | 19.6 | 43.2 | 1.34 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 186 Cr. | 78.6 | 113/67.8 | 39.8 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 21,277 Cr. | 8,511 | 8,877/4,800 | 127 | 272 | 0.28 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,852 Cr. | 641 | 863/548 | 37.5 | 103 | 0.72 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 237 Cr. | 112 | 145/69.9 | 9.40 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 59,531 Cr. | 4,979 | 6,440/4,407 | 27.5 | 961 | 0.80 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,725 Cr. | 953 | 1,304/725 | 31.5 | 249 | 1.15 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 496 Cr. | 869 | 1,754/795 | 12.3 | 724 | 1.32 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 33,902 Cr. | 2,714 | 3,486/2,050 | 37.8 | 294 | 1.33 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,262 Cr. | 292 | 571/258 | 22.9 | 120 | 1.75 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,290 Cr. | 358 | 635/330 | 24.9 | 126 | 0.28 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 18,132.05 Cr | 1,104.61 | | 43.06 | 182.72 | 0.35% | 16.01% | 16.31% | 6.24 |